[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma. - Wikidata - wikimedia - TriplyDB

[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.

[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.

http://www.wikidata.org/entity/Q33395877

about

Brain tumors MiRNA expression patterns predict survival in glioblastoma Newer positron emission tomography radiopharmaceuticals for radiotherapy planning: an overview Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.Visualization, imaging and new preclinical diagnostics in radiation oncology.Imaging biomarkers in primary brain tumours.Molecular imaging of gliomas with PET: opportunities and limitations.Tryptophan PET-defined gross tumor volume offers better coverage of initial progression than standard MRI-based planning in glioblastoma patients An intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomas.From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.[68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning.Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.Technical Issues of [(18)F]FET-PET Imaging for Radiation Therapy Planning in Malignant Glioma Patients - A Review.Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis.Paediatric nuclear medicine imaging.Corticospinal tract-sparing intensity-modulated radiotherapy treatment planning.The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II Response to "reply to [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al.Evaluation of factors influencing 18F-FET uptake in the brain.Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences.Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI.Characterization of an Orthotopic Colorectal Cancer Mouse Model and Its Feasibility for Accurate Quantification in Positron Emission Tomography.O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.[PET-MR in patients with glioblastoma multiforme].Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.Impact of 18F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy.MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?

P2860

Q24605136-E7A95842-E51E-4953-8AD8-0F03A8B84345 Q24629525-82FE6E23-D100-4953-AA15-0890FCBF98F9 Q26767172-3DC63510-EAB5-449E-BFD8-65330C18FE1A Q26853516-E145EB91-430E-4380-805F-B71CB5C08C33 Q30442436-DDDC4CBF-4D89-47B5-BBAC-A5DDCE6237D5 Q30725740-1976531C-CA02-43C6-B8E8-D85288D4B070 Q30880129-E9039E75-8AD5-4501-AACB-897EDB792650 Q33961188-2D6E9A2D-6E0C-4EEC-B082-5BCFEA22091E Q34533978-24138E58-2089-4858-ABA2-962B2013ACDE Q35156126-6AAC837B-0707-4D40-A5BF-4F3B7C3B99AD Q35679377-62EDEEE3-596A-4A00-8CEB-55AB8E81ECA4 Q35788602-02BBB108-B224-45E3-92E4-181C0971FE70 Q36644371-5E8F15EE-7D38-4791-84ED-DAF2005E7EDE Q37037922-B27AD7C0-E4E5-4D7B-8FDF-8AF3616E103A Q37448735-B1C60965-941E-4129-9494-2BC3A6F27107 Q37455074-7CD4DEDA-2B62-4780-92D3-31C5C919E934 Q38051641-AECE4E3F-5B4F-4349-B343-ACEC32F8669A Q38561073-4D360F2E-6F6F-482E-9087-646B1F074337 Q40045765-0F886977-35FE-4E47-A0F1-2B2E608E59F6 Q42041284-40CE75E9-C07A-47A8-B457-19BD92322BDA Q42734117-10CD82E7-2494-4B70-80AF-06CE61B7BC72 Q43120586-516A4FE4-6E65-46E0-BDB2-3F2B578B5C59 Q44799557-26272D63-2D51-48D4-9BEE-606A267BBF66 Q48158155-34CD70B2-B245-46B5-92A8-84E5CF420BD4 Q48240734-8AD78DDE-8687-4AE9-B087-90E7A3C83463 Q48242134-4D578C83-84DF-430A-BE01-440B7A8E4DEE Q48849722-0F73EF19-8464-424C-87E8-A67544DD77E2 Q48934675-B1BD2484-1148-4123-B61F-4F0E2A8D5A49 Q52629217-8DCB3102-6816-444A-90C8-01C3B8E71342 Q55031317-C0E41581-2AC0-437B-B488-33C1DD933007 Q55462196-CE38867B-588B-4C08-9429-9448A0B698DF

P2860

[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.

http://www.wikidata.org/entity/Q33395877

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

[(18)F]Fluoroethyltyrosine- po ...... therapy for high-grade glioma.

@ast

[(18)F]Fluoroethyltyrosine- po ...... therapy for high-grade glioma.

@en

type

label

[(18)F]Fluoroethyltyrosine- po ...... therapy for high-grade glioma.

@ast

[(18)F]Fluoroethyltyrosine- po ...... therapy for high-grade glioma.

@en

prefLabel

[(18)F]Fluoroethyltyrosine- po ...... therapy for high-grade glioma.

@ast

[(18)F]Fluoroethyltyrosine- po ...... therapy for high-grade glioma.

@en

P1433

Q33395877-1546D508-DE34-4E36-ACD9-B554BAE01DFC

P1476

Q33395877-F8B646C5-83EC-4045-A26D-F85331B80813

P2093

Q33395877-09A7917E-9576-4C82-BAF5-5BEE5FF25146

Q33395877-19F278E8-AE84-447A-9998-69927244B667

Q33395877-24527999-DF9E-4192-972C-CE555C38D615

Q33395877-5133E6C3-CB56-4E63-87D1-965A64955BFF

Q33395877-7783A04D-C2F0-40E0-9F60-59ACAB9EDD4D

Q33395877-A0B5C242-106E-44D8-9ACC-85DB3AFBCC86

Q33395877-B603D579-0983-4A7E-AE70-0CE126987B81

Q33395877-C89215E6-FEBF-4C56-B28A-CAC8F9161772

Q33395877-D0F6F9C7-0713-4279-B6A9-BC8306BD3A2D

Q33395877-D26F497A-4F96-491E-8267-73C9D2D27293

P2860

Q33395877-0805790A-2978-4F6D-A007-83CBFBCF7198

Q33395877-0B49BC2C-D2C3-463C-8E49-D829C799A4E6

Q33395877-1DCACCA0-A103-4412-A207-9CC7B592D517

Q33395877-26C5B6FC-E265-4967-A119-BE873F5427A1

Q33395877-2EFD1B3F-90CE-4319-8F00-FFEC89CB9108

Q33395877-3803AD43-EE37-42C6-BC91-6348BC5743EE

Q33395877-4F99098E-5436-4264-B717-23F87E792834

Q33395877-51A504D2-D2BB-44A4-9064-C6DB957AA545

Q33395877-59FC7B5B-1D87-4328-87A7-5CEE9E7559DD

Q33395877-5BCF7534-7FFB-4CA5-BF66-9029D4809D72

P2888

Q33395877-5601E487-A995-44F9-BD75-4D0388977258

P304

Q33395877-8A3F2B63-2EC1-437B-B338-C51AEDC0DEC4

P31

Q33395877-B0CBFC5F-FA80-4B52-BC48-6FA3CE90A33B

P356

Q33395877-F0D29DDA-6551-433E-BC0B-5C681293F650

P478

Q33395877-E7C9EAA2-B109-4451-8E97-89E66A7F398C

P50

Q33395877-5894BFE1-AFF4-4192-BA9F-DA21A780F945

P577

Q33395877-2F311630-06B5-4F96-9660-C5129663BB9C

P6179

Q33395877-3697EEA3-CCE1-42B0-B6CD-AE67A02C65D9

P698

Q33395877-1896940B-29EF-4B99-A8E6-9012E972D7ED

P921

Q33395877-3199AC1A-7532-406C-A029-504A289C1B4F

P932

Q33395877-09AF64E6-B65B-427A-8FF7-C8C2C3E1D554

P356

P1433

Radiation Oncology

P1476

[(18)F]Fluoroethyltyrosine- po ...... therapy for high-grade glioma.

@en

P2093

Damien C Weber

http://www.w3.org/2001/XMLSchema#string

Franz Buchegger

http://www.w3.org/2001/XMLSchema#string

Giovanna Dipasquale

http://www.w3.org/2001/XMLSchema#string

Guy Haller

http://www.w3.org/2001/XMLSchema#string

Hansjorg Vees

http://www.w3.org/2001/XMLSchema#string

Michel Rouzaud

http://www.w3.org/2001/XMLSchema#string

Nathalie Casanova

http://www.w3.org/2001/XMLSchema#string

Osman Ratib

http://www.w3.org/2001/XMLSchema#string

Philippe Nouet

http://www.w3.org/2001/XMLSchema#string

Raymond Miralbell

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineli

O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study.

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality.

The utility of body FDG PET in staging primary central nervous system lymphoma

Open low-field magnetic resonance imaging for target definition, dose calculations and set-up verification during three-dimensional CRT for glioblastoma multiforme.

Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.

(18)F-FDG and (18)F-FET uptake in experimental soft tissue infection.

O-(2-[(18)F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes.

Efficient routine production of the 18F-labelled amino acid O-2-18F fluoroethyl-L-tyrosine.

P2888

P304

44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1748-717X-3-44

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1043303521

http://www.w3.org/2001/XMLSchema#string

P698

19108742

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

2628662

http://www.w3.org/2001/XMLSchema#string